The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Singh, A., Dilnawaz, F., Mewar, S., Sharma, U., Jagannathan, N. R., & Sahoo, S. K. (2011) · ACS Applied Materials & Interfaces · doi:10.1021/am101196v · Cited by 161
Self-citationRetractedDrug combination studies and their synergy quantification using the Chou-Talalay method
Chou, T.-C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1947 · Cited by 5,739
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Parveen, S., Misra, R., & Sahoo, S. K. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.05.016 · Cited by 1,436
Self-citationNanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Self-citationCombined therapy for cancer of the anal canal
Nigro, N. D., Vaitkevicius, V. K., & Considine, B. (1974) · Diseases of the Colon & Rectum · doi:10.1007/bf02586980 · Cited by 1,115
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 938
Maeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
The present and future of nanotechnology in human health care
Sahoo, S. K., Parveen, S., & Panda, J. J. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.11.008 · Cited by 905
Self-citationDendrimer-based drug and imaging conjugates: design considerations for nanomedical applications
Menjoge, A. R., Kannan, R. M., & Tomalia, D. A. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.009 · Cited by 795
DeAngelis, L. M., Seiferheld, W., Schold, S. C., Fisher, B., & Schultz, C. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.013 · Cited by 738
Cancer nanotechnology: application of nanotechnology in cancer therapy
Misra, R., Acharya, S., & Sahoo, S. K. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.006 · Cited by 702
Self-citationDhar, S., Liu, Z., Thomale, J., Dai, H., & Lippard, S. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803036e · Cited by 700
Greco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 652
Nanoparticle-assisted Combination Therapies for Effective Cancer Treatment
Hu, C.-M. J., Aryal, S., & Zhang, L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.13 · Cited by 564
Nanotechnology Safety Concerns Revisited
Stern, S. T., & McNeil, S. E. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfm169 · Cited by 560
Nanotechnology in ocular drug delivery
Sahoo, S. K., Dilnawaz, F., & Krishnakumar, S. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.021 · Cited by 510
Self-citationMagnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging
Jain, T. K., Richey, J., Strand, M., Leslie-Pelecky, D. L., Flask, C. A., & Labhasetwar, V. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.004 · Cited by 491
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Self-citationAn overview of cancer multidrug resistance: a still unsolved problem
Lage, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8111-5 · Cited by 408
Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy
Dilnawaz, F., Singh, A., Mohanty, C., & Sahoo, S. K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.057 · Cited by 385
Self-citationPersidis, A. (1999) · Nature Biotechnology · doi:10.1038/5289 · Cited by 372
Gulley, J. L., Arlen, P. M., Bastian, A., Morin, S., Marte, J., Beetham, P., Tsang, K.-Y., Yokokawa, J., Hodge, J. W., Ménard, C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2062 · Cited by 370
Nanotechnology in Ocular Drug Delivery
Patel, D., Pathak, D., & Giradkar, P. (2021) · Nanocarriers: Drug Delivery System · doi:10.1007/978-981-33-4497-6_18 · Cited by 362
Narayanan, N. K., Nargi, D., Randolph, C., & Narayanan, B. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24336 · Cited by 353
Wong, H. L., Bendayan, R., Rauth, A. M., Xue, H. Y., Babakhanian, K., & Wu, X. Y. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101154 · Cited by 344
Patil, Y., Sadhukha, T., Ma, L., & Panyam, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.021 · Cited by 317
Multidrug Resistance Reversal Agents
Robert, J., & Jarry, C. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030183a · Cited by 292
Cytotoxic and genotoxic effects of silver nanoparticles in testicular cells
Asare, N., Instanes, C., Sandberg, W. J., Refsnes, M., Schwarze, P., Kruszewski, M., & Brunborg, G. (2012) · Toxicology · doi:10.1016/j.tox.2011.10.022 · Cited by 288
Li, R., Wu, R., Zhao, L., Wu, M., Yang, L., & Zou, H. (2010) · ACS Nano · doi:10.1021/nn9011225 · Cited by 245
Lammers, T., Subr, V., Ulbrich, K., Peschke, P., Huber, P. E., Hennink, W. E., & Storm, G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.040 · Cited by 240
Misra, R., & Sahoo, S. K. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100455h · Cited by 232
Self-citationLigand-based targeted therapy for cancer tissue
Das, M., Mohanty, C., & Sahoo, S. K. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902780166 · Cited by 230
Self-citationBava, S. V., Puliappadamba, V. T., Deepti, A., Nair, A., Karunagaran, D., & Anto, R. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410647200 · Cited by 229
Wu, J. H., Lu, Y., Lee, A., Pan, X., Yang, X., Zhao, X. B., & Lee, R. J. (2007) · PubMed · Cited by 216
Batist, G., Gelmon, K. A., Chi, K. N., Miller, W. H., Chia, S. K. L., Mayer, L. D., Swenson, C. E., Janoff, A. S., & Louie, A. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0515 · Cited by 213
Song, X. R., Cai, Z., Zheng, Y., He, G., Cui, F. Y., Gong, D. Q., Hou, S. X., Xiong, S. J., Lei, X. J., & Wei, Y. Q. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.018 · Cited by 211
Nanomedicine: Clinical Applications of Polyethylene Glycol Conjugated Proteins and Drugs
Parveen, S., & Sahoo, S. K. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645100-00002 · Cited by 189
Self-citationExploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics
Tekade, R. K., Dutta, T., Gajbhiye, V., & Jain, N. K. (2009) · Journal of Microencapsulation · doi:10.1080/02652040802312572 · Cited by 181
Wang, F., Zhang, D., Zhang, Q., Chen, Y., Zheng, D., Hao, L., Duan, C., Jia, L., Liu, G., & Liu, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.041 · Cited by 170
Biologically Optimized Nanosized Molecules and Particles: More than Just Size
Longmire, M. R., Ogawa, M., Choyke, P. L., & Kobayashi, H. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200111p · Cited by 167
Serpe, L., Catalano, M. G., Cavalli, R., Ugazio, E., Bosco, O., Canaparo, R., Muntoni, E., Frairia, R., Gasco, M. R., Eandi, M., et al. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.026 · Cited by 165
Milane, L., Duan, Z., & Amiji, M. (2011) · Molecular Pharmaceutics · doi:10.1021/mp1002653 · Cited by 161
Yadav, S. K., van Vlerken, L. E., Little, S. R., & Amiji, M. M. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0790-y · Cited by 152
Taratula, O., Garbuzenko, O. B., Savla, R., et al. (2010) · Current Drug Delivery · doi:10.2174/156720111793663642 · Cited by 151
Thickness of Multiwalled Carbon Nanotubes Affects Their Lung Toxicity
Fenoglio, I., Aldieri, E., Gazzano, E., Cesano, F., Colonna, M., Scarano, D., Mazzucco, G., Attanasio, A., Yakoub, Y., Lison, D., et al. (2012) · Chemical Research in Toxicology · doi:10.1021/tx200255h · Cited by 128
A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs
Shin, H.-C., Alani, A. W. G., Cho, H., Bae, Y., Kolesar, J. M., & Kwon, G. S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2000549 · Cited by 126
Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
Mohanty, C., Das, M., Kanwar, J. R., & Sahoo, S. K. (2010) · Current Drug Delivery · doi:10.2174/156720111793663606 · Cited by 108
Self-citationHPMA-based polymer conjugates with drug combination
Krakovičová, H., Etrych, T., & Ulbrich, K. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.03.011 · Cited by 99
Hubensack, M., Müller, C., Höcherl, P., Fellner, S., Spruß, T., Bernhardt, G., & Buschauer, A. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0323-9 · Cited by 97
Use of nanoscale delivery systems to maintain synergistic drug ratiosin vivo
Dicko, A., Mayer, L. D., & Tardi, P. G. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.538678 · Cited by 86
Multi-drug delivery to tumor cells via micellar nanocarriers
Katragadda, U., Teng, Q., Rayaprolu, B. M., Chandran, T., & Tan, C. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.033 · Cited by 59
Lancet, J. E., Baer, M. R., Durán, G. E., List, A. F., Fielding, R. M., Marcelletti, J. F., Multani, P. S., & Sikic, B. I. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.09.015 · Cited by 54
Verschraegen, C. F., Skubitz, K. M., DAUD, A. I., Kudelka, A. P., Rabinowitz, I., Allievi, C., Eisenfeld, A. J., Singer, J. W., & Oldham, F. B. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0813-8 · Cited by 46
Acharya, S., & Sahoo, S. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.043 · Cited by 32
Self-citationTherapeutic Strategy for Treatment of Metastatic Non-Small Cell Lung Cancer
Berhoune, M., Banu, E., Scotté, F., Prognon, P., Oudard, S. M., & Bonan, B. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l200 · Cited by 30
Tanabe, M., Ito, Y., Tokudome, N., Sugihara, T., Miura, H., Takahashi, S., Seto, Y., Iwase, T., & Hatake, K. (2009) · Breast Cancer · doi:10.1007/s12282-009-0093-0 · Cited by 28
Chiang, C.-T., Yeh, P.-Y., Gao, M., Chen, C.-W. D., Yeh, L.-C., Feng, W.-C., Kuo, S., Hsu, C., Lu, Y., & Cheng, A. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.07.005 · Cited by 23
Logman, J., Heeg, B. M. S., Botteman, M. F., Kaura, S., & van Hout, B. A. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp560 · Cited by 20
Carboplatin—gemcitabine in the therapy of advanced ovarian cancer: dose reduction consideration
Dasanu, C. A., Herzog, T. J., & Alexandrescu, D. T. (2009) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155209105396 · Cited by 12
Cited by
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,663
Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects
Begines, B., Ortiz, T., Pérez-Aranda, M., Martínez, G., Merinero, M., Argüelles-Arias, F., & Alcudia, A. (2020) · Nanomaterials · doi:10.3390/nano10071403 · Cited by 1,061
Martins, P., Jesus, J., Santos, S., Raposo, L., Roma-Rodrigues, C., Baptista, P., & Fernandes, A. (2015) · Molecules · doi:10.3390/molecules200916852 · Cited by 716
The Impact of Nanoparticle Protein Corona on Cytotoxicity, Immunotoxicity and Target Drug Delivery
Corbo, C., Molinaro, R., Parodi, A., Toledano Furman, N. E., Salvatore, F., & Tasciotti, E. (2016) · Nanomedicine · doi:10.2217/nnm.15.188 · Cited by 692
Metadata
- Authors
- Parhi, P., Mohanty, C., & Sahoo, S. K.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 17
- Issue
- 17-18
- Pages
- 1044-1052
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W1989109875
- Cited by
- 573
- References
- 60
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.